M. Alex Michaels

Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody

J. Kremer, M. Weinblatt, J. Vencovský, 2018, Arthritis & rheumatology.